Bladder Tumors: TULA® Laser as a New Option

Medications and Recurrent Bladder Tumors? – New Hope with TULA® Laser Treatment

Bladder cancer is one of the most common tumor diseases of the urinary tract. In Germany, there are approximately 30,000 new cases each year. About two-thirds of these cases are superficial bladder tumors that have not penetrated the deeper muscle layers of the bladder wall and are therefore well treatable. However, the high recurrence rate, meaning the repeated occurrence of tumors after initial therapy, is problematic.

Superficial Tumors and Recurrences

In non-muscle-invasive bladder tumors, the risk of recurrences often arises shortly after the first removal of the tumor. This is due to the biological nature of the disease: New tumors can develop in other areas of the bladder mucosa, necessitating repeated interventions. Especially in older patients and those with pre-existing conditions, each new surgical treatment under general anesthesia can represent an additional burden. 

Also, certain medications, particularly blood-thinning or anticoagulant drugs, can complicate the performance of conventional surgical procedures. In such cases, doctors and patients often face the challenge of finding a safe and at the same time gentle therapy.

TULA® Laser Treatment: Gentle Alternative

The TULA® Laser Therapy (Trans Urethral Laser Ablation) is a modern, minimally invasive procedure for treating bladder tumors. In this method, a flexible endoscope is inserted into the bladder through the urethra, through which precise laser energy is applied to specifically remove tumor tissue.

A particular advantage of the TULA® laser treatment is that it can be performed on an outpatient basis and often even without general anesthesia. The highly precise laser light of the biolitec® laser allows for the removal of tumors while largely preserving the surrounding healthy tissue. Additionally, the laser has a strong hemostatic effect, minimizing the risk of bleeding even in patients on blood thinners.

Why TULA® Laser Therapy is Sensible for Recurrent Tumors

Thanks to the low burden and outpatient execution, the TULA® laser treatment opens up new possibilities, especially for recurrent bladder tumors. Since no major surgical intervention under general anesthesia is necessary, it is particularly suitable for older patients, patients with comorbidities, or patients who can only be operated on to a limited extent due to their medication.

Moreover, the TULA® laser therapy can be repeated multiple times without the patient having to endure a significant burden from a surgical procedure each time. The precision of the laser treatment also contributes to preserving surrounding tissue and reducing possible complications.

Conclusion

For patients with recurrent or difficult-to-treat bladder tumors, the TULA® laser therapy offers a gentle and effective treatment option. It allows for the precise removal of tumors, typically reduces the need for general anesthesia, and lowers the risk of side effects due to its hemostatic properties – even in patients on anticoagulant medication.